2414. Deputy Ken O'Flynn asked the Minister for Health to outline the governance arrangements governing reimbursement rule changes, claim validation criteria, claim rejection criteria and reference pricing decisions within the Primary Care Reimbursement Service, including the decision-making authorities involved, review mechanisms and oversight structures. [44052/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn .
3,835 questions match, newest first.
2415. Deputy Ken O'Flynn asked the Minister for Health the number of pharmacy reimbursement claims submitted, approved, adjusted, rejected and successfully appealed in each year from 2020 to date, together with the most common reasons recorded for claim rejection or adjustment. [44053/26]
2416. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, assurance review, risk assessment or value-for-money review of PCRS reimbursement decision-making processes, claim validation controls, claim rejection procedures or reference pricing arrangements has been completed since 2020 and to provide the dates and findings of such reviews. [44054/26]
2417. Deputy Ken O'Flynn asked the Minister for Health whether Children’s Health Ireland has conducted any internal audit, external audit, clinical audit, utilisation review, value-for-money review, peer review, quality assurance review or independent assessment since 2020 concerning elective paediatric surgical decision-making, theatre allocation, waiting-list prioritisation or the application of medical necessity c…
2418. Deputy Ken O'Flynn asked the Minister for Health whether Children’s Health Ireland operates a formally documented definition, policy, protocol, framework or clinical criteria for determining that an elective paediatric procedure is medically indicated; whether such criteria are standardised across all CHI sites and specialties; and if she will provide a copy of the relevant documentation. [44056/26]
2419. Deputy Ken O'Flynn asked the Minister for Health whether Children’s Health Ireland, the HSE or her Department has undertaken any modelling, forecasting, scenario analysis, demand analysis or capacity-planning assessment since 2020 examining the impact of theatre allocation decisions, theatre utilisation rates or specialty-based theatre scheduling on paediatric waiting lists, waiting times or patient outcomes; a…
2420. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has ever undertaken, commissioned or reviewed any epidemiological assessment, public health impact assessment or retrospective study examining potential health outcomes associated with elevated manganese levels in drinking water supplies since 2020; and if details will be provided. [44062/26]
2421. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has considered establishing any surveillance, monitoring or reporting mechanism for potential adverse health outcomes associated with prolonged exposure to contaminants in public drinking water supplies, including manganese; and if not, the reasons for this decision. [44063/26]
2422. Deputy Ken O'Flynn asked the Minister for Health the number of children currently awaiting elective procedures in Children’s Health Ireland broken down by Clinical Priority Category; and the average waiting time within each category. [44064/26]
2423. Deputy Ken O'Flynn asked the Minister for Health the percentage of children treated within the target waiting time applicable to their assigned Clinical Priority Category in Children’s Health Ireland in each year since 2020. [44065/26]
2424. Deputy Ken O'Flynn asked the Minister for Health whether Children’s Health Ireland reports performance against Clinical Priority Category waiting-time targets to the HSE or their Department; and if so, the frequency and format of such reporting. [44066/26]
2425. Deputy Ken O'Flynn asked the Minister for Health whether any national written criteria, guidance documents, policy directives, clinical governance documents or decision-support frameworks currently exist which distinguish between procedures regarded as medically necessary, elective, quality-of-life, cosmetic or discretionary for public funding purposes; and if so, if she will provide details of each such docume…
2426. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has conducted any review since 2020 of variation in decision-making between hospitals, specialties or Health Regions regarding eligibility for publicly funded procedures; and if any such review has been undertaken, if she will provide the findings and recommendations. [44068/26]
2427. Deputy Ken O'Flynn asked the Minister for Health whether any national audit has been undertaken since 2020 examining consistency in decisions regarding access to publicly funded procedures across different clinical specialties; and if not, whether she considers the absence of a national classification framework creates a risk of inconsistent decision-making. [44069/26]
2428. Deputy Ken O'Flynn asked the Minister for Health the governance mechanism that exists to ensure that a procedure approved for public funding in one hospital or specialty is assessed against equivalent criteria in another hospital or specialty. [44070/26]
2429. Deputy Ken O'Flynn asked the Minister for Health whether her Department maintains a list of procedures which are excluded from public funding solely on the basis that they are considered cosmetic, non-essential or quality-of-life procedures; and if so, if she will provide details. [44071/26]
2430. Deputy Ken O'Flynn asked the Minister for Health whether the HSE, NTPF or any acute hospital records separately the number of orthopaedic patients removed from waiting lists through administrative validation due to non-response, patient choice, treatment elsewhere, clinical review or other reasons; and if so, to provide the figures for 2025. [44072/26]
2431. Deputy Ken O'Flynn asked the Minister for Health whether an audit, review or analysis has been undertaken since 2020 to determine the number of patients removed from orthopaedic waiting lists through administrative validation who subsequently re-presented, were re-referred or were restored to a waiting list for the same condition; and if so, to provide details. [44073/26]
2432. Deputy Ken O'Flynn asked the Minister for Health whether the Department, HSE or NTPF has assessed the absence of end-to-end waiting-time measurement from GP referral to completed orthopaedic procedure as a governance, performance-management or patient-safety risk; and if so, to provide the findings of that assessment. [44074/26]
2433. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1029 of 19 May 2026, the estimated additional annual PCRS expenditure attributable solely to the 2022 steri-neb salamol price uplift, excluding any increase arising from changes in prescribing volume or item numbers; and if they will provide the methodology used in calculating that estimate. [44075/26]
2434. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken or commissioned any literature review, evidence assessment or toxicological review since 2020 regarding potential neurological, developmental or cognitive effects associated with long-term exposure to manganese concentrations between 50 µg/l and 80 µg/l in drinking water; and if so, if details of each review will be provided. [44082…
2435. Deputy Ken O'Flynn asked the Minister for Health whether the HSE possesses any documented risk assessment, scientific briefing, technical paper or expert advice supporting its position that there is currently no scientific evidence of adverse health effects at manganese concentrations up to 80 µg/l; and if copies of such documents will be provided. [44083/26]
2436. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has reviewed any scientific literature published since July 2024 concerning manganese exposure through drinking water; and whether any such evidence has prompted consideration of revising the July 2024 FAQ guidance. [44084/26]
2437. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records, at national level, the number of patients awaiting orthopaedic outpatient assessment who have not yet been placed on an inpatient or day-case surgical waiting list; and if so, the current number, broken down by hospital group and orthopaedic subspecialty. [44094/26]
2438. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can quantify the average period between referral to orthopaedic outpatient services and subsequent placement on an inpatient or day-case waiting list for knee replacement surgery. [44096/26]